Replies to post #49778 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

I think the PR for the next molecule (which could start in July) will be carefully orchestrated to deliver the best shareholder value. Look at the value Clovis achieved at their peak with just a few hints of success in EGFR NSCLC. If Ariad hints at a target such as KRAS or MET, it will be off to the races. Genetech's recent failure in MET shows how hard this really is.

[biotech_researcher]

Here's a crazy thought, the lower dosing successes makes one wonder if Rida should be tried at lower doses.

2da, just the opposite. Rida improved PFS by just a couple of weeks verses the placebo, so if anything, they should have increased the dose.

[IIIverson]

$ARIA BOLLINGER BAND SQUEEZER COMING UP!!!!!

[IIIverson]

Look at the VOLUME of MONEY!!! $ARIA CHART


The lower two indicators show the Money Flow & On Blanance Volume. A nice consolidation and break out (with VOLUME)yesterday.

Don't forget about the Bollinger Band squeeze.